Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Selvita

Market Cap: zł553.4m

Provides drug discovery, drug development, and contract testing services in Poland.

Bioceltix

Market Cap: zł490.2m

Engages in the development of stem cell-based biopharmaceuticals for veterinary use.

Ryvu Therapeutics

Market Cap: zł342.2m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

Molecure

Market Cap: zł117.4m

A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.

Poltreg

Market Cap: zł106.5m

A biotechnology company, researches and develops therapies for autoimmune diseases.